EP2024497A4 - LIGA AND LIGB PROTEINS (IG LEPTOSPIRE TYPE DOMAINS (LIG)) FOR IMMUNIZATION AND DIAGNOSIS - Google Patents

LIGA AND LIGB PROTEINS (IG LEPTOSPIRE TYPE DOMAINS (LIG)) FOR IMMUNIZATION AND DIAGNOSIS

Info

Publication number
EP2024497A4
EP2024497A4 EP06828120A EP06828120A EP2024497A4 EP 2024497 A4 EP2024497 A4 EP 2024497A4 EP 06828120 A EP06828120 A EP 06828120A EP 06828120 A EP06828120 A EP 06828120A EP 2024497 A4 EP2024497 A4 EP 2024497A4
Authority
EP
European Patent Office
Prior art keywords
leptospire
ligb
liga
lig
immunization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06828120A
Other languages
German (de)
French (fr)
Other versions
EP2024497A2 (en
Inventor
Marco Alberto Medeiros
Reis Mitemayer Galvao Dos
Silva Everton Fagonde Da
Alan John Alexander Mcbride
Julio Henrique Rosa Croda
Joao Gabriel Rosa Ramos
Odir Antonio Dellagostin
Flavia Weykamp Cruz Mcbride
Albert Icksang Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacao Oswaldo Cruz
Cornell Research Foundation Inc
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Publication of EP2024497A2 publication Critical patent/EP2024497A2/en
Publication of EP2024497A4 publication Critical patent/EP2024497A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP06828120A 2005-12-19 2006-12-19 LIGA AND LIGB PROTEINS (IG LEPTOSPIRE TYPE DOMAINS (LIG)) FOR IMMUNIZATION AND DIAGNOSIS Withdrawn EP2024497A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0505529-6A BRPI0505529A (en) 2005-12-19 2005-12-19 alloy and ligb (leptospiral ig-like (lig) domains) proteins for vaccination and diagnosis
PCT/BR2006/000283 WO2007070996A2 (en) 2005-12-19 2006-12-19 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis

Publications (2)

Publication Number Publication Date
EP2024497A2 EP2024497A2 (en) 2009-02-18
EP2024497A4 true EP2024497A4 (en) 2010-03-17

Family

ID=38189000

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06828120A Withdrawn EP2024497A4 (en) 2005-12-19 2006-12-19 LIGA AND LIGB PROTEINS (IG LEPTOSPIRE TYPE DOMAINS (LIG)) FOR IMMUNIZATION AND DIAGNOSIS

Country Status (4)

Country Link
EP (1) EP2024497A4 (en)
BR (1) BRPI0505529A (en)
CA (1) CA2634214A1 (en)
WO (1) WO2007070996A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2486345C (en) * 2002-05-17 2012-08-14 Fundacao Oswaldo Cruz - Fiocruz Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
CA2820949C (en) * 2002-10-10 2015-12-08 Cornell Research Foundation, Inc. Novel immunogenic proteins of leptospira

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "UNIPROT:O05734", 1 July 1997 (1997-07-01), XP055325287, Retrieved from the Internet <URL:http://ibis.internal.epo.org/exam/dbfetch.jsp?id=UNIPROT:O05734> [retrieved on 20161201] *
DATABASE EMBL [online] 13 February 2002 (2002-02-13), "Sequence 3 from Patent WO0191536.", XP002565996, retrieved from EBI accession no. EMBL:AX358376 Database accession no. AX358376 *
DATABASE EMBL [online] 25 March 2003 (2003-03-25), "Leptospira interrogans serovar copenhageni putative immunoglobulin-like protein A (ligA) gene, complete cds.", retrieved from EBI accession no. EMBL:AY221109 Database accession no. AY221109 *
DATABASE Geneseq [online] 23 March 2001 (2001-03-23), "Yeast NORF gene SAGE tag oligonucleotide SEQ ID NO:870.", XP002565995, retrieved from EBI accession no. GSN:AAF34131 Database accession no. AAF34131 *
PALANIAPPAN R U M ET AL: "Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 70, no. 11, 1 November 2002 (2002-11-01), pages 5924 - 5930, XP002348167, ISSN: 0019-9567, DOI: 10.1128/IAI.70.11.5924-5930.2002 *
See also references of WO2007070996A2 *

Also Published As

Publication number Publication date
WO2007070996A3 (en) 2007-09-20
EP2024497A2 (en) 2009-02-18
BRPI0505529A (en) 2007-09-25
CA2634214A1 (en) 2007-06-28
WO2007070996A2 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
EP1946105A4 (en) DIAGNOSIS AND SURVEILLANCE OF RENAL DISEASE USING NGAL LEVELS
EA201100231A1 (en) DIAGNOSTIC ANALYSIS BASED ON ANTIBODIES
ATE539069T1 (en) ISOTOPICALLY LABELED BENZOFURAN COMPOUNDS AS IMAGING AGENTS FOR AMYLOIDOGENIC PROTEINS
EP2119469A4 (en) MICRO NEEDLE DEVICE FOR DIAGNOSING ALLERGIES
EP2059807A4 (en) DIAGNOSIS OF PNEUMOCOCCUS PNEUMONIA
CY1118880T1 (en) HUMAN ANTI-IL-23 ANTIBODIES, COMPOSITIONS, METHODS AND USES
EP2158326A4 (en) BIOLOGICAL MARKERS FOR THE DIAGNOSIS OF AUTOIMMUNE DISEASE
DK1924600T3 (en) IDENTIFICATION OF TUMOR-ASSOCIATED ANTIGENS FOR DIAGNOSIS AND THERAPY
EP1930426A4 (en) COMPOSITION AND METHOD FOR DIAGNOSIS OF KIDNEY CANCER AND EVALUATION OF VITAL PROGNOSIS OF A PATIENT WITH KIDNEY CANCER
DK1712920T3 (en) Early diagnosis of conformational diseases
EP1846015A4 (en) METHOD, COMPOSITIONS AND CLASSIFICATION FOR DIAGNOSING AND TREATING A TUMOR
NO982060D0 (en) Ultrasound flow analysis with color imaging, especially for medical diagnosis
DK1651260T3 (en) Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods for their use
EP1806581A4 (en) SYSTEM FOR DIAGNOSING A DISEASE
NO20061169L (en) Probes for diseases in which amyloid accumulates agents for color amyloid drugs for the treatment and prophylaxis of diseases with accumulated content and probes for diagnoses of neurofibrilar nodules and drugs for color neurofibrilar nodules
BRPI0619357B8 (en) monoclonal antibodies, pharmaceutical composition, vaccine, use thereof for treatment or prevention of alzheimer&#39;s disease, in vitro methods for diagnosing and identifying appropriate compounds for immunization of alzheimer&#39;s disease, and kits
EP1884197A4 (en) IMAGING DIAGNOSTIC DEVICE
EP2089813A4 (en) DIAGNOSTIC AND ERROR REPORT FOR CLASSICAL TAGGING PROBLEMS
EP2319924A4 (en) POLYPEPTIDE MARKER FOR THE DIAGNOSIS OF ARTERIOSCLEROSIS, METHOD FOR DETECTION OF ARTERIOSCLEROSIS USING THE MARKER OR SIMILAR, AND DIAGNOSTIC KIT FOR ARTERIOSCLEROSIS
EP2198292A4 (en) BETTER DIAGNOSIS OF ALZHEIMER&#39;S DISEASE
EP1907409A4 (en) METHODS OF DIAGNOSIS OR PROGNOSIS OF A LATE START DISEASE
EP1680666A4 (en) ANTI-THERAPEUTIC HUMAN ANTIBODY DETECTION
BRPI0712273A2 (en) ISOLATED ANTIBODIES, IMMUNOGLOBULIN POLYPEPTIDES, HEPSIN ANTIBODY, NUCLEIC ACID MOLECULE, HOST CELL, CELL LINE, METHODS TO PRODUCE THE ANTIBODY, TO DIAGNOSTIC THE PRESENCE OF HYDRENE, THERAPEUTIC DISEASE, HEATING, TO DIAGNOSE A DYSFUNCTION, COMPOSITION, ARRANGEMENT OR CHIP OF PROTEIN AND KIT
EP1742654A4 (en) ANTI-LFL2 ANTIBODIES FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF CANCER
ATE458006T1 (en) HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO LIPOPOLYSACCHARIDES (LPS) OF SEROTYPE IATS O6 OF PSEUDOMONAS AERUGINOSA

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081107

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DOS REIS, MITEMAYER, GALVAO

Inventor name: MCBRIDE, ALAN, JOHN, ALEXANDER

Inventor name: RAMOS, JOAO, GABRIEL, ROSA

Inventor name: DA SILVA, EVERTON, FAGONDE

Inventor name: KO, ALBERT, ICKSANG

Inventor name: MCBRIDE, FLAVIA, WEYKAMP, CRUZ

Inventor name: DELLAGOSTIN, ODIR, ANTONIO

Inventor name: CRODA, JULIO, HENRIQUE, ROSA

Inventor name: MEDEIROS, MARCO, ALBERTO

A4 Supplementary search report drawn up and despatched

Effective date: 20100212

17Q First examination report despatched

Effective date: 20100416

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: FUNDACAO OSWALDO CRUZ - FIOCRUZ

Owner name: CORNELL RESEARCH FOUNDATION, INC.

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180322

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180802